Company profile ALT
After 39 days of this quarter the interest is at 95.0. Based on that we can calculate that during remaining 52 days it will total up to 222.0. Altimmune, Inc. expected interest is significantly higher compared to same quarter last year (+753.8%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 203 inf% QoQ | 194 -4.4% QoQ | 122 -37.1% QoQ |
| 2020 | 86 inf% YoY -29.5% QoQ | 107 -47.3% YoY 24.4% QoQ | 157 -19.1% YoY 46.7% QoQ | 132 8.2% YoY -15.9% QoQ |
| 2021 | 65 -24.4% YoY -50.8% QoQ | 88 -17.8% YoY 35.4% QoQ | 69 -56.1% YoY -21.6% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 121 86.2% YoY inf% QoQ | 74 -15.9% YoY -38.8% QoQ | 69 0.0% YoY -6.8% QoQ | 71 inf% YoY 2.9% QoQ |
| 2023 | 26 -78.5% YoY -63.4% QoQ | 151 104.1% YoY 480.8% QoQ | 62 -10.1% YoY -58.9% QoQ | 176 147.9% YoY 183.9% QoQ |
| 2024 | 95 265.4% YoY -46.0% QoQ | - | - | - |
The average 5 years interest of Altimmune, Inc. was 7.92 per week. The last year interest of Altimmune, Inc. compared to the last 5 years has changed by 23.86%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -1.7%.
There is not enough data for Altimmune obesity treatment to provide analysis
There is not enough data for Altimmune obesity treatment to provide correlation calculation
There is not enough data for Altimmune obesity treatment to provide analysis
There is not enough data for Altimmune liver disease treatment to provide analysis
There is not enough data for Altimmune liver disease treatment to provide correlation calculation
There is not enough data for Altimmune liver disease treatment to provide analysis
There is not enough data for Pemvidutide clinical trials to provide analysis
There is not enough data for Pemvidutide clinical trials to provide correlation calculation
There is not enough data for Pemvidutide clinical trials to provide analysis
There is not enough data for HepTcell immunotherapy to provide analysis
There is not enough data for HepTcell immunotherapy to provide correlation calculation
There is not enough data for HepTcell immunotherapy to provide analysis
After 39 days of this quarter the interest is at 37.0. Based on that we can calculate that during remaining 52 days it will total up to 86.0. Altimmune stock price expected interest is significantly lower compared to previous quarter (-52.2%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 116 inf% QoQ | 156 34.5% QoQ | 52 -66.7% QoQ |
| 2020 | 147 inf% YoY 182.7% QoQ | 168 44.8% YoY 14.3% QoQ | 509 226.3% YoY 203.0% QoQ | 366 603.8% YoY -28.1% QoQ |
| 2021 | 380 158.5% YoY 3.8% QoQ | 325 93.5% YoY -14.5% QoQ | 116 -77.2% YoY -64.3% QoQ | 160 -56.3% YoY 37.9% QoQ |
| 2022 | 259 -31.8% YoY 61.9% QoQ | 119 -63.4% YoY -54.1% QoQ | 84 -27.6% YoY -29.4% QoQ | 114 -28.8% YoY 35.7% QoQ |
| 2023 | 118 -54.4% YoY 3.5% QoQ | 137 15.1% YoY 16.1% QoQ | 229 172.6% YoY 67.2% QoQ | 180 57.9% YoY -21.4% QoQ |
| 2024 | 37 -68.6% YoY -79.4% QoQ | - | - | - |
The average 5 years interest of Altimmune stock price was 14.45 per week. The last year interest of Altimmune stock price compared to the last 5 years has changed by -10.45%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 66.11%.
There is not enough data for Altimmune MD to provide analysis
There is not enough data for Altimmune MD to provide correlation calculation
There is not enough data for Altimmune MD to provide analysis
After 39 days of this quarter the interest is at 92.0. Based on that we can calculate that during remaining 52 days it will total up to 215.0. Altimmune -stock -company expected interest is significantly higher compared to same quarter last year (+72.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 59 | 80 35.6% QoQ | 66 -17.5% QoQ | 38 -42.4% QoQ |
| 2020 | 178 201.7% YoY 368.4% QoQ | 261 226.2% YoY 46.6% QoQ | 430 551.5% YoY 64.8% QoQ | 249 555.3% YoY -42.1% QoQ |
| 2021 | 280 57.3% YoY 12.4% QoQ | 218 -16.5% YoY -22.1% QoQ | 123 -71.4% YoY -43.6% QoQ | 38 -84.7% YoY -69.1% QoQ |
| 2022 | 71 -74.6% YoY 86.8% QoQ | 66 -69.7% YoY -7.0% QoQ | 63 -48.8% YoY -4.5% QoQ | 45 18.4% YoY -28.6% QoQ |
| 2023 | 125 76.1% YoY 177.8% QoQ | 72 9.1% YoY -42.4% QoQ | 19 -69.8% YoY -73.6% QoQ | 183 306.7% YoY 863.2% QoQ |
| 2024 | 92 -26.4% YoY -49.7% QoQ | - | - | - |
The average 5 years interest of Altimmune -stock -company was 10.56 per week. The last year interest of Altimmune -stock -company compared to the last 5 years has changed by -20.45%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 58.19%.